Chapter 31. Prodrug Approach in Drug Design
- 1 January 1975
- book chapter
- Published by Elsevier
Abstract
No abstract availableThis publication has 59 references indexed in Scilit:
- The Metabolic Fate of CyclophosphamideDrug Metabolism Reviews, 1975
- Some (pharmacological) properties of chloracetaldehyde, an oxidation product and potential metabolite of cyclophosphamideInflammation Research, 1974
- A pharmacodynamic model for cell-cycle-specific chemotherapeutic agentsJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Narcotic antagonists. 1. Isomeric sulfate and acetate esters of naloxone (N-allylnoroxymorphone)Journal of Medicinal Chemistry, 1973
- Quantitaton of rate of gastrointestinal and buccal absorption of acidic and basic drugs based on extraction theoryJournal of Pharmacokinetics and Biopharmaceutics, 1973
- Activation of cyclophosphamide in man and animalsCancer, 1971
- Tumour-growth inhibitorynitrofphenylaziridines and related compounds structure-activity relationshipsChemico-Biological Interactions, 1969
- Labile lipophilic derivatives of norepinephrine capable of crossing the blood-brain barrierCellular and Molecular Life Sciences, 1969
- Synthesis of Possible Cancer Chemotherapeutic Agents Based on Enzyme Rationale VIJournal of Pharmaceutical Sciences, 1967
- Synthesis of Derivatives of Glutamine as Model Substrates for Anti-tumor Agents1Journal of the American Chemical Society, 1959